Sagility India provide technology-enabled business solutions and services to clients in the U.S. healthcare industry. They are a pure-play healthcare focused services provider, and their clients include Payers (U.S. health insurance companies, which finance and reimburse the cost of health services) and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies).

Sagility India, an Book Built Issue amounting to ₹2,106.60 Crores, consisting entirely an Offer for Sale of 7,021.99 Lakh Shares. The subscription period for the Sagility India IPO opens on November 05, 2024, and closes on November 07, 2024. The allotment is expected to be finalized on or about Friday, November 08, 2024, and the shares will be listed on the BSE & NSE with a tentative listing date set on or about Tuesday, November 12, 2024.

The Share price band of Sagility India IPO is set at ₹28 to ₹30 per equity share. The Market Capitalisation of the Sagility India Limited at IPO price of ₹30 per equity share will be ₹14,043.98 Crores. The lot size of the IPO is 500 shares. Retail investors are required to invest a minimum of ₹15,000, while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (420 shares), amounting to ₹2,10,000.

ICICI SECURITIES LIMITED, IIFL SECURITIES LIMITED, JEFFERIES INDIA PRIVATE LIMITED and J. P. MORGAN INDIA PRIVATE LIMITED are the book-running lead manager while LINK INTIME INDIA PRIVATE LIMITED is the registrar for the Issue. 

Sagility India Limited IPO GMP Today
The Grey Market Premium of Sagility India Limited IPO is expected to be ₹0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Sagility India Limited IPO Live Subscription Status Today: Real-Time Updates
As of 07:00 PM on 07 November 2024, the Sagility India IPO live subscription status shows that the IPO subscribed 3.20 times on its Final day of subscription period. Check the Sagility India IPO Live Subscription Status today at BSE.

Sagility India IPO Anchor Investors Report
Sagility India has raised ₹945.40 Crores from Anchor Investors at a price of ₹30 per shares in consultation of the Book Running Lead Managers. The company allocated 31,51,34,668 equity shares to the Anchor Investors. Check Full List of Sagility India Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion. 

Sagility India Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online 
Sagility India IPO allotment date is 08 November, 2024, Friday. Sagility India IPO Allotment will be out on 8th November 2024 and will be live on Registrar Website from the allotment date. Check Sagility India Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Sagility India Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

- Submit the details to check your allotment status.

Objectives of Sagility India Limited IPO
Sagility India Issue Proceeds from the Fresh Issue will be utilized towards the following objects : 
1. To chieve the benefits of listing the Equity Shares on the Stock Exchanges
2. To carry out the Offer for Sale of up to 702,199,262 Equity Shares of face value of ₹ 10 each by the Promoter Selling Shareholder. 

Refer to Sagility India Limited RHP for more details about the Company.

Check latest IPO Review & analysis, Live IPO GMP today, Live IPO Subscription Status Today, Share Price, Financial Information and other details before applying in the IPO.

The Upcoming IPOs in this week and coming weeks are Archit Nuwood Industries Limited, Swiggy, ACME Solar Holdings, Sagility India, Neelam Lines and Garments.

No Current active IPO.

The Closed IPOs are Afcons Infrastructure Limited IPO, Usha Financial Services Limited IPO, Godavari Biorefineries Limited IPO, Usha Financial Services Limited IPO, United Heat Transfer Limited IPO, OBSC Perfection Limited IPO, Danish Power Limited IPO.

The Recently Listed IPOs which is available for trading in stock Market are Waaree Energies Limited IPO, Deepak Builders & Engineers India Limited IPO, Premium Plast Limited IPO, Shiv Texchem Limited IPO, Garuda Construction and Engineering Limited IPO, Khyati Global Ventures Limited IPO, Paramount Dye Tec Limited IPO, Subam Papers Limited IPO, Neopolitan Pizza and Foods Limited IPO, HVAX Technologies Limited IPO, Saj Hotels Limited IPO, Forge Auto International Limited IPO, Nexxus Petro Industries Limited IPO, Diffusion Engineers Limited IPO, Saharsa Electronic Solutions Limited IPO, Thinking Hats Entertainment Solutions Limited IPO, Unilex Colours and Chemicals Limited IPO and many more.

Read more

About Sagility India Limited

Sagility India provide technology-enabled business solutions and services to clients in the U.S. healthcare industry. They are a pure-play healthcare focused services provider, and their clients include Payers (U.S. health insurance companies, which finance and reimburse the cost of health services) and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies). Their services to Payers cater to various aspects of their operations including (i) core benefits administration functions such as claims management, enrolment, benefits plan building, premium billing, credentialing, and provider data management and (ii) clinical functions such as utilization management, care management, and population health management. Their services to Providers include revenue cycle management functions such as financial clearance, medical coding, billing, and accounts receivable follow-up services. Additionally, they also provide some of the services that they provide to Payers to pharmacy benefit managers (“PBMs”) that manage prescription drugs for Members (i.e., insured persons) under health insurance plans. They deliver these services leveraging their tools and platforms, as needed, through their capable talent pool from their five global service delivery locations in India, the Philippines, the U.S., Jamaica and Colombia.

The Company were ranked as a Leader by Avasant in their Clinical Services Business Process Transformation RadarView report 2023 and as a Leader in Everest’s Healthcare Payer Operations PEAK Matrix Assessment 2023. All of their clients are located in the U.S. As of June 30, 2024, their five largest client groups (i.e., client entities together with their affiliates) had an average tenure of 17 years with the Business. Further, during the Financial Years 2024 and 2023 and the quarter ended June 30, 2024, they have added 22 new clients. In the Financial Year 2024, they helped their Payer clients process 105 million claims and handle over 75 million Member and Provider interactions. 

As of June 30, 2024, the Company had 35,858 employees, of which 60.68% were women. The Bankers of the Sagility India Limited are HDFC Bank Limited, Standard Chartered Bank, Axis Bank Limited, ICICI Bank Limited and Hongkong and Shanghai Banking Corporation Limited. 

Healthcare operations overview
Healthcare payers engage in a diverse set of activities to ensure operational efficiency and seamless experience for the individuals they cover, referred to as members. These activities can be categorized into seven broad value chain segments across front- and back-office, as shown in the process map below. The process map excludes non-business process operations such as pureplay Information Technology (IT) development and SaaS, IT services, and maintenance.

Apart from core care delivery, healthcare providers undertake a wide range of activities to reduce administrative burden, improve efficiency, and ensure robust patient experience. The processes involved can be categorized into five broad value chain segments across front-office and back-office, as shown in the process map below. The process map excludes non-business process operations such as pure play IT development and SaaS, IT services, and maintenance.

The total outsourced operations spend in the US healthcare market grew at a CAGR of ~6.1% from CY 2014 to CY 2023. As a result, in 2023, the aggregate outsourcing penetration rate in the US healthcare operations market stood at 21.5-23.5%, resulting in a total outsourced operations spend of approximately US$ 45.0 billion (₹ 3.8 trillion). The healthcare payer market had a relatively higher outsourcing penetration at 22.0-24.0%, while the healthcare provider market had a relatively lower outsourcing penetration at 19.5-21.5% in 2023.

Further, the growth in the outsourced operations market is expected to outpace the growth in the insourced market. While the overall healthcare outsourced operations market is expected to grow at a CAGR of approximately 8.7%, the payer outsourced market is forecasted to grow at a CAGR of approximately 7.0% from 2023-28. The provider operations outsourced market, on the other hand, is expected to grow at a CAGR of approximately 12.5%.

Generative AI refers to the application of artificial intelligence techniques that can generate new content in the form of text, images, videos, audio, and more. This technology is built on underlying models that are trained on large, extensive datasets. Some of the prominent GenAI models in the market include OpenAI's GPT, Google's Gemini, and Meta's LLaMA. GenAI has the potential to improve organizational productivity by streamlining a variety of tasks, thereby increasing efficiency, optimizing processes, and enhancing the overall patient/member experience. 

While GenAI shows promise in simplifying tasks with low-to-moderate complexity, the solutions still require humanin-the-loop engagements in the healthcare industry due to the degree of risk involved and regulatory concerns. Human intervention ensures that AI-generated outputs are reliable and error-free, particularly in critical decision-making processes. Moreover, the dynamic nature of healthcare demands adaptability and contextual understanding, areas wherein human expertise complements AI capabilities.

SAGILITY INDIA LIMITED COMPETITIVE STRENGTHS
1. Leader in the large and resilient U.S. Payer and Provider solutions market
2. Domain expertise in healthcare operations, with end-to-end service offerings to Payers and Providers
3. Suite of scalable, technology-enabled services and solutions, supported by proprietary tools and platforms
4. Deep, long-term, expanding client relationships across healthcare Payers and Providers
5. Multi-shore, scalable and flexible delivery model with certified data protection and service standards
6. Strong financial performance and high margins
7. Experienced management and board, motivated employee base, marquee sponsor support and a sustainability focused culture

SAGILITY INDIA LIMITED STRATEGIES
1. Strengthen their relationships with existing clients, expand their offerings and increase the share of their wallets
2. Establish new client relationships across categories
3. Enhance their portfolio of technology tools and platforms
4. Pursue strategic acquisitions and collaborations

SAGILITY INDIA LIMITED RISK FACTORS & CONCERNS
1. The business is solely focused on the U.S. healthcare industry and may be adversely affected by factors affecting the U.S. healthcare industry, including a decline in the growth of the U.S. healthcare industry, reduction in outsourcing and other trends.
2. Goodwill and other intangible assets are their largest assets.
3. One of their Independent Directors has received summons in relation to an ongoing investigation by SEBI of Linde India Limited and the matter is currently pending.
4. Anti-outsourcing legislation could adversely affect the business.
5. As a significant portion of the business is attributable to certain large client groups in the U.S., the business and profitability is dependent on their continuing relationships with such key clients.
6. They reported a restated loss for the period from July 28, 2021 until March 31, 2022.